DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde


Gluz O, Nitz U, Liedtke C. et al.
Prognostic impact of anthracyclines and immune/proliferation markers in TNBC according to pCR after de-escalated neoadjuvant chemotherapy with 12 weeks og nab-paclitaxel/carboplatin or gemcitabine: Survival results of WSG-ADAPT-TN phase II trial. ESMO 2018; München, Poster.

Download Bibliographical Data

Search in: